Pharmaceuticals 2011, 4(1), 1-6; doi:10.3390/ph4010001
Review

Blood Pressure-Lowering Aspects of Lipid-Lowering and Anti-Diabetic Drugs

1 Department of Clinical Sciences, Lund University Hospital, Malmö, Sweden 2 Department of Preventive Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
* Author to whom correspondence should be addressed.
Received: 20 December 2010; Accepted: 22 December 2010 / Published: 23 December 2010
(This article belongs to the Special Issue Antihypertensive Drugs)
PDF Full-text Download PDF Full-Text [36 KB, uploaded 23 December 2010 10:36 CET]
Abstract: Several studies have shown that blood pressure can be lowered by the use of drugs that are not traditional antihypertensive drugs. This might be of clinical importance when many risk patients are treated by combination drug therapy in order to prevent cardiovascular disease by way of improving the cardiovascular risk factor profile.
Keywords: blood pressure; glitazone; metformin; orlistat; rimonabant; sibutramine; sitagliptin; statin

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Nilsson, P.M.; Cifkova, R. Blood Pressure-Lowering Aspects of Lipid-Lowering and Anti-Diabetic Drugs. Pharmaceuticals 2011, 4, 1-6.

AMA Style

Nilsson PM, Cifkova R. Blood Pressure-Lowering Aspects of Lipid-Lowering and Anti-Diabetic Drugs. Pharmaceuticals. 2011; 4(1):1-6.

Chicago/Turabian Style

Nilsson, Peter M.; Cifkova, Renata. 2011. "Blood Pressure-Lowering Aspects of Lipid-Lowering and Anti-Diabetic Drugs." Pharmaceuticals 4, no. 1: 1-6.

Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert